Medicare Enrolled
Dr. Lawrence Gervasi, MD
Urology Physician · Middleburg Heights, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gervasi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gervasi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gervasi
Dr. Lawrence Gervasi is an urology physician in Middleburg Heights, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gervasi performed 11,514 Medicare services across 2,695 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gervasi received a total of $1,110,207 from 70 pharmaceutical and/or device companies across 1613 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gervasi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in OH
$1,110,207 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,514
Medicare services
Top 2% in OH for urology physician
2,695
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~576 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,160 | $18 | $33 |
| BCG treatment for bladder cancer | 1,894 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
936 | $3 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
699 | $82 | $202 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 414 | $132 | $732 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
336 | $34 | $104 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
253 | $7 | $61 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $57 | $119 |
| PSA test (prostate cancer screening) | 206 | $18 | $106 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
204 | $8 | $15 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
139 | $22 | $123 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
114 | $38 | $96 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
110 | $14 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $104 | $296 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
84 | $46 | $244 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
68 | $2 | $24 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
67 | $47 | $233 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
62 | $63 | $329 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
61 | $61 | $130 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
60 | $153 | $722 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
55 | $23 | $447 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
48 | $11 | $55 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
45 | $75 | $1,195 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
41 | $90 | $655 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
28 | $34 | $103 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
24 | $426 | $3,844 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
24 | $84 | $1,131 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
22 | $44 | $209 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
17 | $22 | $141 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
12 | $271 | $1,271 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
50.0% medium
49.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,110,207
Total received (2018-2024)
Avg $158,601/year across 7 years
Top 0% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,613
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,060,977 (95.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,250 (3.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,981 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$152,152
2023
$177,657
2022
$182,488
2021
$104,761
2020
$91,148
2019
$198,015
2018
$203,987
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$71,240
Janssen Biotech, Inc.
$38,656
Bayer Healthcare Pharmaceuticals Inc.
$17,259
Sumitomo Pharma America, Inc.
$16,652
Dendreon Pharmaceuticals LLC
$7,128
Blue Earth Diagnostics Limited
$259
Tolmar, Inc.
$163
Tempus AI, Inc
$111
PROGENICS PHARMACEUTICALS, INC.
$110
Novartis Pharmaceuticals Corporation
$76
PFIZER INC.
$73
ABC Home Medical Supply, Inc.
$63
Boston Scientific Corporation
$57
Verity Pharmaceuticals Inc.
$52
Axonics, Inc.
$38
IMMUNITYBIO, INC.
$37
ConvaTec Inc.
$34
Telix Pharmaceuticals
$24
Medtronic, Inc.
$20
Myriad Genetic Laboratories, Inc.
$19
Laborie Medical Technologies Corp.
$18
ABBVIE INC.
$17
AstraZeneca Pharmaceuticals LP
$16
Calyxo, Inc.
$15
Olympus America Inc.
$13
Top 3 companies account for 83.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$420,277
Janssen Biotech, Inc.
$178,024
Bayer HealthCare Pharmaceuticals Inc.
$165,340
Janssen Scientific Affairs, LLC
$99,809
Bayer Healthcare Pharmaceuticals Inc.
$70,710
Sumitomo Pharma America, Inc.
$50,399
Dendreon Pharmaceuticals LLC
$40,449
Myovant Sciences Inc.
$28,776
PFIZER INC.
$22,524
Amgen Inc.
$11,843
Astellas Pharma Global Development
$7,773
Clovis Oncology, Inc.
$3,254
Exelixis Inc.
$1,980
GENZYME CORPORATION
$1,834
AstraZeneca Pharmaceuticals LP
$1,322
Blue Earth Diagnostics Limited
$846
TOLMAR Pharmaceuticals, Inc.
$826
Tolmar, Inc.
$381
UROGEN PHARMA, INC.
$180
Antares Pharma, Inc.
$173
UroGen Pharma, Inc.
$156
Endo Pharmaceuticals Inc.
$153
Progenics Pharmaceuticals, Inc.
$153
Avadel Specialty Pharmaceuticals, LLC
$147
C. R. Bard, Inc. & Subsidiaries
$136
AbbVie, Inc.
$134
Verity Pharmaceuticals Inc.
$126
PROCEPT BioRobotics Corporation
$122
Allergan, Inc.
$121
ABBVIE INC.
$119
Teleflex LLC
$117
Tempus AI, Inc
$111
PROGENICS PHARMACEUTICALS, INC.
$110
ConvaTec Inc.
$110
AbbVie Inc.
$103
Axonics, Inc.
$103
Sun Pharmaceutical Industries Inc.
$103
UROVANT SCIENCES INC
$102
Ferring Pharmaceuticals Inc.
$100
Medtronic USA, Inc.
$96
Rochester Medical Corporation
$94
Coloplast Corp
$78
MEDIVATION FIELD SOLUTIONS LLC
$77
Novartis Pharmaceuticals Corporation
$76
ABC Home Medical Supply, Inc.
$63
Boston Scientific Corporation
$57
Merck Sharp & Dohme LLC
$54
Telix Pharmaceuticals
$51
ACCORD HEALTHCARE, INC.
$48
Acerus Pharmaceuticals Corporation
$38
IMMUNITYBIO, INC.
$37
COLOPLAST CORP
$36
Allergan Inc.
$36
Merck Sharp & Dohme Corporation
$32
Clarus Therapeutics Inc.
$31
Foundation Medicine, Inc.
$27
Mission Pharmacal Company
$26
DENTSPLY IH Inc.
$25
Medtronic, Inc.
$20
Myriad Genetic Laboratories, Inc.
$19
Laborie Medical Technologies Corp.
$18
DENTSPLY IH AB
$16
Accord Healthcare, Inc.
$16
Calyxo, Inc.
$15
KOELIS Inc.
$15
Olympus America Inc.
$13
Photocure Inc
$13
Metuchen Pharmaceuticals
$13
Zyla Life Sciences, Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 68.8% of all-time payments
Associated products mentioned in payments ›
AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Aquoral · Axonics · Axumin · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CABOMETYX · CAMCEVI · CVAC ASPIRATION SYSTEM · CYSVIEW · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENESIS · GENTLECATH · GENTLECATH GLIDE · Genesis · GentleCath · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Non-Covered · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · RUBRACA · Rezum Generator · Rubraca · SPRIX · SUTENT · SpeediCath · Stendra · Synthroid · TAXOTERE · TITAN · TOVIAZ · Titan · Trelstar · Trinity · UROLIFT · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for urology physician in OH.
Geographic Context
Urology physicians within 10 mi
78
Per 100K population
6.2
County median income
$62,823
Nearest hospital
SOUTHWEST GENERAL HEALTH CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gervasi is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with speaking/promotional industry engagement in the top 0% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gervasi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Gervasi performed 5,160 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gervasi receive payments from pharmaceutical companies?
Yes. Dr. Gervasi received a total of $1,110,207 from 70 companies across 1,613 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gervasi's costs compare to other urology physicians in Middleburg Heights?
Dr. Gervasi's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gervasi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Middleburg Heights
Browse urology physicians in Middleburg Heights ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology